| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/03/2004 | US6686156 Generating copies of preferential nucleotdie sequences; obtain sample nucleotide sequences, hydridize to primers, extend primer, digest and recover preferential sequences |
| 02/03/2004 | US6686155 Treatment of tumor; obtain tissue sample, extract nucleotide sequences, amplify, detect preferential nucleotide sequences, incbate with antitumor agent, monitor sequence expression, adjustment in expression indicates effective antitumor agent |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6686152 Methods employing oligonucleotide-binding e-tag probes |
| 02/03/2004 | US6686151 Immunological detection of RNA:DNA hybrids on microarrays |
| 02/03/2004 | US6686150 Amplification of nucleic acids with electronic detection |
| 02/03/2004 | US6686148 Methods for targeting RNA molecules |
| 02/03/2004 | US6686147 Diagnosing lung cancer; hybridizing to nucleotide sequence 4 or full length complement under high stringency conditions and determining expression |
| 02/03/2004 | US6686146 Prognostic methods for prediction of progression of normal and hyperplastic mammary cells to carcinoma |
| 02/03/2004 | US6686145 Imparting fluorescent properties to target materials by covalent and noncovalent association |
| 02/03/2004 | US6685944 Modification of immunogenic epitopes of the hepatitis c virus core protein to elicit an enhanced immune response |
| 02/03/2004 | US6685841 Nanostructured devices for separation and analysis |
| 02/03/2004 | CA2118594C Max: a helix-loop-helix zipper protein that forms a sequence-specific dna-binding complex with myc and mad |
| 01/31/2004 | CA2432676A1 Development of an in vivo functional assay for proteases |
| 01/29/2004 | WO2004010537A2 Flexible biochip |
| 01/29/2004 | WO2004010146A1 Screening method and anti-tumor drug candidate obtained therefrom |
| 01/29/2004 | WO2004010144A1 Probe carrier and method of producing same |
| 01/29/2004 | WO2004010141A1 Method for the identification of ligands |
| 01/29/2004 | WO2004010136A1 Drug discovery method |
| 01/29/2004 | WO2004010108A2 Method for the identification of ligands |
| 01/29/2004 | WO2004010107A2 Method for determining the regulation of xenobiotic removal |
| 01/29/2004 | WO2004010106A2 METHODS FOR IDENTIFYING SMALL MOLEDULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY |
| 01/29/2004 | WO2004010105A2 Photonic signal reporting of electrochemical events |
| 01/29/2004 | WO2004010103A2 Impedance based devices and methods for use in assays |
| 01/29/2004 | WO2004010102A2 Impedance based apparatuses and methods for analyzing cells and particles |
| 01/29/2004 | WO2004010101A2 Detection of chemical ligation using fluorescence quenching leaving groups |
| 01/29/2004 | WO2004010074A2 Biosensor arrays and methods |
| 01/29/2004 | WO2004009851A2 Method for pcr cleanup and oligonucleotide removal |
| 01/29/2004 | WO2004009848A1 Microparticle based signal amplification for the detection of analytes |
| 01/29/2004 | WO2004009847A2 Functional screening method involving protein translocation/redistribution |
| 01/29/2004 | WO2004009846A1 Quantitative multiplex amplificaction on a genomic scale, and applications for detecting genomic rearrangements |
| 01/29/2004 | WO2004009845A2 Methods of screening for schizophrenia |
| 01/29/2004 | WO2004009844A1 The use of nucleotide sequences as carrier of information |
| 01/29/2004 | WO2004009843A2 Detection of microorganisms |
| 01/29/2004 | WO2004009842A2 Methods for identifying genes related to malfunctions of the central nervous system |
| 01/29/2004 | WO2004009840A1 Capture and detection of microbes by membrane methods |
| 01/29/2004 | WO2004009839A2 Oligonucleotides for detecting micro-organisms |
| 01/29/2004 | WO2004009837A2 A high resolution typing system for pathogenic mycobacterium tuberculosum |
| 01/29/2004 | WO2004009835A2 Method for identifying cellular growth inhibitors |
| 01/29/2004 | WO2004009833A2 Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases |
| 01/29/2004 | WO2004009812A1 Novel protein participating in nuclear migaration of substance in nerve cells, gene encoding the protein and utilization of the same |
| 01/29/2004 | WO2004009807A1 Two-phase alcohol dehydrogenase-based coupled enzymatic reaction system |
| 01/29/2004 | WO2004009803A2 Regulation of human hepsin |
| 01/29/2004 | WO2004009799A2 Ion channel receptor and uses thereof |
| 01/29/2004 | WO2004009791A2 Modulators of b-lymphocyte activation, myosin-1f compositions and methods of use |
| 01/29/2004 | WO2004009787A2 Method and apparatus for manipulating polarizable analytes via dielectrophoresis |
| 01/29/2004 | WO2004009782A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | WO2004009773A2 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 01/29/2004 | WO2004009765A2 Strategies for gene expression analysis |
| 01/29/2004 | WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 01/29/2004 | WO2004009760A2 Cytochrome p450 genetic variations |
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009758A2 Embryonic stem cell markers and uses thereof |
| 01/29/2004 | WO2004009677A1 Immobilization layer for biosensors |
| 01/29/2004 | WO2004009626A1 Novel gene associated with rheumatoid arthritis |
| 01/29/2004 | WO2004009540A2 Methods and kits for transferases |
| 01/29/2004 | WO2004009497A2 Method of monitoring biofouling in membrane separation systems |
| 01/29/2004 | WO2004009033A2 Methods of modulating proliferative conditions |
| 01/29/2004 | WO2004009032A2 Method and composition for treating and preventing hepatitis b infection and symptoms thereof |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | WO2004008946A2 Methods of diagnosing and treating pre-eclampsia or clamp |
| 01/29/2004 | WO2004008938A2 A novel method to identify targets for antibiotic development |
| 01/29/2004 | WO2004008841A2 Dna fingerprinting for cannabis sativa (marijuana) using short tandem repeat (str) markers |
| 01/29/2004 | WO2003100418A3 Method and kit for measuring mitochondrial activity in isolated cells |
| 01/29/2004 | WO2003100413A3 Surface acoustic wave sensors and methods for detecting target analytes |
| 01/29/2004 | WO2003087297A3 Infectious disease microarray |
| 01/29/2004 | WO2003085098A3 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti |
| 01/29/2004 | WO2003070878A3 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 01/29/2004 | WO2003064675A3 Rapid methods and devices for the detection of coliform and the detection and confirmation of e. coli |
| 01/29/2004 | WO2003054157A3 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 01/29/2004 | WO2003052099A3 Methods of parallel gene cloning and analysis |
| 01/29/2004 | WO2003052069A3 FLJ1115 AS MODIFIER OF THE Apaf-1 PATHWAY AND METHODS OF USE |
| 01/29/2004 | WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 01/29/2004 | WO2003046209A3 Method and biosensor for detecting macromolecular biopolymers |
| 01/29/2004 | WO2003042403A3 Biochips for characterizing biological processes |
| 01/29/2004 | WO2003040680A3 Fluorescence-quenching used to detect nucleic acid oligomer hybridization events at high salt concentrations |
| 01/29/2004 | WO2003038113A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 01/29/2004 | WO2003028663A3 Prolyl-4-hydroxylases |
| 01/29/2004 | WO2003025141A3 Genetic analysis for stratification of cancer risk |
| 01/29/2004 | WO2003023060A3 Method and kit for diagnosing or controlling the treatment of breast cancer |
| 01/29/2004 | WO2003020953A3 Compositions and methods relating to colon specific genes and proteins |
| 01/29/2004 | WO2003020878A3 Amplification and detection reagents for hiv-1 |
| 01/29/2004 | WO2003019194A3 Displacement assay for detecting ligate-ligand association events |
| 01/29/2004 | WO2003016562A3 Compositions and methods for detecting multidrug resistant strains of m. tuberculosis having mutations in genes of the mutt family |
| 01/29/2004 | WO2003014402A3 Method for identification of type specific polynucleotide sequences |
| 01/29/2004 | WO2003008635A3 η-SECRETASE IN VITRO SCREENING ASSAY |
| 01/29/2004 | WO2003004275A9 Droplet dispensing system |
| 01/29/2004 | WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002090503A3 Anti-microbial peptides and compositions |
| 01/29/2004 | WO2002081739A3 Non-enzymatic liposome-linked closely spaced array electrodes assay (nel-ela) for detecting and quantifying nucleic acids |
| 01/29/2004 | WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | WO2002070737A3 Compositions and methods relating to osteoarthritis |
| 01/29/2004 | WO2002063307A3 Methods of assessing wolframin protein activity |
| 01/29/2004 | US20040019935 Gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene |
| 01/29/2004 | US20040019919 Calsyntenin-1-3 proteins, predominantly expressed in the nervous system , useful for the screening and for the preparation of a medicament for the treatment of nervous system disorders, most preferably brain |
| 01/29/2004 | US20040019432 System and method for integrated computer-aided molecular discovery |
| 01/29/2004 | US20040019418 Wheel lifted and grounded identification for an automotive vehicle |
| 01/29/2004 | US20040019193 Contacting a sample from the patient with an antibody to Mob-5; and detecting the binding of the antibody with antigen in the sample, wherein binding indicates the presence of Mob-5 antigen sample, an indicator of cancer |